Joint Formulary & PAD

Nortriptyline - Pain (Neuropathic)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Off Label
Restrictions / Comments :
Important

Second line option where amitriptyline was ineffective / not tolerated.

ONLY 10mg and 25mg TABLETS are agreed for this indication.

PAD Profile

ChemicalSubstance :
Nortriptyline
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
neuropathic pain, Tricyclic antidepressants, TCAs, tricyclics, PHN, post herpetic neuralgia, postherpetic neuralgia, diabetic neuropathy
Brand Names Include :
Allegron
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey & Sussex APC approved the formulary alignment for nortriptyline 10 mg and 25 mg tablets as GREEN in Surrey, for second-line treatment of neuropathic pain where amitriptyline is ineffective or not tolerated, in line with the existing GREEN formulary status in Sussex.

Other Indications

Below are listed other indications that Nortriptyline is used to treat.